NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

424 hedge funds and large institutions have $8.35B invested in Neurocrine Biosciences in 2022 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 161 increasing their positions, 143 reducing their positions, and 43 closing their positions.

Holders
424
Holders Change
+21
Holders Change %
+5.21%
% of All Funds
6.71%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
68
Increased
161
Reduced
143
Closed
43
Calls
$89.6M
Puts
$79.5M
Net Calls
+$10.1M
Net Calls Change
+$17.4M

Top Buyers

1
American Century Companies
1
American Century Companies
Missouri
$74.6M
2
AC
2
Armistice Capital
New York
$60.9M
3
LGM
3
Logos Global Management
California
$44.5M
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$58.9M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$36.5M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$592M
2
Citadel Advisors
2
Citadel Advisors
Florida
$8.73M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$22.5M
4
EVM
4
Eaton Vance Management
Massachusetts
$137M
5
PHS
5
PFM Health Sciences
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$1.09B 11,595,417 +118,872 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$823M 8,777,458 -10,533 -0.1%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$592M 6,309,763 -1,136,076 -15%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$402M 4,288,770 -70,875 -2%
State Street
5
State Street
Massachusetts
$350M 3,734,170 +7,029 +0.2%
BG
6
Bellevue Group
Switzerland
$283M 3,023,451 -157,100 -5%
JPMorgan Chase & Co
7
JPMorgan Chase & Co
New York
$282M 3,005,309 +24,210 +0.8%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$160M 1,703,093 -158,896 -9%
DM
9
Deerfield Management
New York
$155M 1,657,800 +279,855 +20%
Goldman Sachs
10
Goldman Sachs
New York
$140M 1,496,452 -28,063 -2%
EVM
11
Eaton Vance Management
Massachusetts
$137M 1,456,048 -390,867 -21%
DCP
12
DSM Capital Partners
Florida
$127M 1,351,331 -56,866 -4%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$120M 1,284,039 +46,491 +4%
Renaissance Technologies
14
Renaissance Technologies
New York
$120M 1,280,123 -143,541 -10%
APM
15
Avidity Partners Management
Texas
$109M 1,160,000 -100,000 -8%
Franklin Resources
16
Franklin Resources
California
$105M 1,115,742 +151,921 +16%
CAM
17
Congress Asset Management
Massachusetts
$104M 1,110,848 +201,760 +22%
RSCM
18
Rock Springs Capital Management
Maryland
$104M 1,105,000 – –
Brown Advisory
19
Brown Advisory
Maryland
$94.6M 1,008,750 +72,266 +8%
Northern Trust
20
Northern Trust
Illinois
$82.8M 883,091 +8,680 +1%
O
21
OrbiMed
New York
$82.1M 875,515 -56,400 -6%
Ameriprise
22
Ameriprise
Minnesota
$77.9M 831,461 +124,005 +18%
Norges Bank
23
Norges Bank
Norway
$77.9M 831,059 +62,643 +8%
American Century Companies
24
American Century Companies
Missouri
$74.6M 795,848 +670,415 +534%
PAMS
25
Pictet Asset Management (Switzerland)
Switzerland
$72.7M 775,375 +363,942 +88%
1
2 3 4 5